This product is a revolutionary ultra-rapid glass thawing solution specifically designed for oocytes and blastocysts. Its core formulation utilizes a 1M sucrose solution, innovatively streamlining the traditional four-step thawing process into a “one-step direct” operation. This significantly reduces the complexity and variability of manual procedures, markedly enhancing laboratory efficiency. Rigorously validated, this ultra-rapid thawing method demonstrates no statistically significant differences from conventional methods in key metrics such as cell viability, meeting clinical application standards while maintaining excellent compatibility with mainstream cryoprotectant brands. Notably, this technology not only drastically reduces procedure time to approximately 1 minute (a 90% reduction compared to traditional methods), effectively minimizing embryo exposure to cryoprotectants, but also contributes to achieving superior clinical pregnancy rates. The product is based on a stable HEPES-M199 buffer system, supplemented with human serum albumin (HSA), which together provide a safe and stable environmental support for cell recovery.